Skip to main content
. 2020 Feb 10;2020:6079713. doi: 10.1155/2020/6079713

Table 1.

Baseline characteristics.

Total collective Ischemic HFrEF (n = 57) Nonischemic HFrEF (n = 55) p value
Age, years (IQR) 65.6 (57.1-70.7) 66.6 (57.7-70.8) 61.9 (56.4-70.7) 0.094
Male gender, n (%) 84 (75.7) 47 (82.5) 37 (69.1) 0.098
BMI, kg/m2 (IQR) 28.1 (24.6-31.3) 28.7 (25.3-31.9) 27.5 (24.1-30.8) 0.994
Diabetes mellitus, n (%) 42 (38.2) 23 (41.1) 19 (32.5) 0.478
Hypertension, n (%) 76 (68.5) 43 (75.4) 33 (61.8) 0.187
Current smoker, n (%) 20 (18.0) 11 (19.3) 9 (16.4) 0.682
Hypercholesterolemia, n (%) 59 (53.2) 39 (68.4) 20 (36.4) 0.002
Coronary vessel disease, n (%) 59 (53.2) 57 (100.0) 2 (3.6) <0.001
Atrial fibrillation, n (%) 56 (50.5) 28 (49.1) 28 (51.9) 0.774
Left ventricular ejection faction 0.802
 >40%, n (%) 27 (32.7) 18 (32.7) 19 (35.8)
 30-40%, n (%) 39 (36.4) 21 (38.2) 18 (34.0)
 <30%, n (%) 32 (29.9) 16 (29.1) 16 (30.2)
Nt-proBNP, pg/ml (IQR) 1120 (443-2632) 1353 (449-3105) 851 (431-2117) 0.790
eGFR, ml/min/1.73m2 (IQR) 45.9 (35.0-54.7) 38.9 (32.2-50.2) 52.4 (41.9-59.9) 0.823
CRP, mg/dl (IQR) 0.36 (0.18-0.71) 0.32 (0.18-0.66) 0.37 (0.16-0.83) 0.520

Categorical data are presented as counts and percentages, continuous as median and IQR (interquartile range). Categorical data are analyzed using the chi-square test, continuous data using the Kruskal-Wallis test.